Human sFLT1 Leads to Severe Changes in Placental Differentiation and Vascularization in a Transgenic hsFLT1/rtTA FGR Mouse Model

The anti-angiogenic soluble fms-like tyrosine kinase 1 (sFLT1) is one of the candidates in the progression of preeclampsia, often associated with fetal growth restriction (FGR). Therapeutic agents against preeclampsia with/without FGR, as well as adequate transgenic sFLT1 mouse models for testing su...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Front Endocrinol (Lausanne)
Prif Awduron: Vogtmann, Rebekka, Kühnel, Elisabeth, Dicke, Nikolai, Verkaik-Schakel, Rikst Nynke, Plösch, Torsten, Schorle, Hubert, Stojanovska, Violeta, Herse, Florian, Köninger, Angela, Kimmig, Rainer, Winterhager, Elke, Gellhaus, Alexandra
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2019
Pynciau:
Endocrinology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437783/
https://ncbi.nlm.nih.gov/pubmed/30949132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00165
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg